Positive

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to .75.”

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75.”

admin December 13, 2025

POTOMAC, MD / ACCESS Newswire / December 10, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a...

Read More

American Eagle’s celebrity-led marketing turns sales growth positive

American Eagle’s celebrity-led marketing turns sales growth positive

admin December 8, 2025

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. American Eagle...

Read More

Business Strategy: Positive report on tourism validates further investment

Business Strategy: Positive report on tourism validates further investment

admin August 30, 2024

Listen to this article Kenton Tsoodle As summer winds down and many of us have wrapped up our summer travels,...

Read More

Screenshot_165

Why Market Timing Isn’t the Only Path to Better Investment Decisions

admin July 25, 2026

AI in Sales and Marketing Market to Exceed USD 214.0 Billion by 2033

AI in Sales and Marketing Market to Exceed USD 214.0 Billion by 2033

admin April 11, 2026

What Oracle’s Layoffs Really Signal For B2B Marketing, Sales, And Revenue Operations

What Oracle’s Layoffs Really Signal For B2B Marketing, Sales, And Revenue Operations

admin April 10, 2026

Could U.S. pushback on foreign data laws recast global business operations?

Could U.S. pushback on foreign data laws recast global business operations?

admin April 2, 2026

Bombardier delivers the first Global 8000 to NetJets

Bombardier delivers the first Global 8000 to NetJets

admin April 1, 2026